SFM
IPXL

Systematic Financial Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Systematic Financial Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-73,050
Closed -$1.73M – 695
2016
Q3 		$1.73M Buy
73,050
+12,330
+20% +$331K 0.02% 428
2016
Q2 		$1.75M Buy
+60,720
New +$1.98M 0.02% 435

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Systematic Financial Management's IPXL Position: Q4 2016 in Review

Systematic Financial Management sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 73,050 shares — an estimated $1.73M sold.

Systematic Financial Management first reported a position in IPXL in Q2 2016 and held it in 2 quarters. The position peaked at $1.75M in Q2 2016. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

  • Systematic Financial Management reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
  • Systematic Financial Management sold 73,050 Impax Laboratories, Inc. shares in Q4 2016, an estimated $1.73M.
  • Systematic Financial Management first reported a position in Impax Laboratories, Inc. in Q2 2016 and held it in 2 quarters.
  • Systematic Financial Management's Impax Laboratories, Inc. position peaked at $1.75M in Q2 2016.
  • 198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Systematic Financial Management's 13F filing for Q4 2016, filed 10 Feb 2017.